Latham & Watkins represented Coherus in the transaction.Coherus BioSciences, Inc. (Coherus or the Company) (Nasdaq: CHRS) has entered into a loan agreement with investment funds managed by…
Coherus BioSciences’ $300 Million Credit Financing with Pharmakon Advisors
